Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited) (Parenthetical)

v3.22.2
Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
shares in Thousands, $ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Allowance for accounts receivable $ 2,286 $ 2,154
Series F Preferred stock, par value $ 0.001 $ 0.001
Series F Preferred stock, shares authorized 18 18
Series F Preferred stock, shares issued 0 0
Series F Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 180,000 180,000
Common stock, shares issued 6,857 6,855
Common stock, shares outstanding 6,149 6,147